COMMUNIQUÉS West-GlobeNewswire

-
Inventiva announces filing of its 2024 Universal Registration Document and 2024 Annual Report on Form 20-F
15/04/2025 -
Inventiva annonce le dépôt de son Document d’Enregistrement Universel 2024 et de son Rapport Annuel 2024 (« Form 20-F »)
15/04/2025 -
POPULUS Health Technologies Names Edith Hodkinson Chief Strategy Officer and Kim Levy VP of Marketing
15/04/2025 -
Best Legal Steroids For Muscle Growth, Cutting, Buying Anabolic Steroids, Testosterone As A Steroid, Steroids For Sale, How To Get Steroids, Metabolic Steroids (By CrazyBulk)
15/04/2025 -
Elumina Health Announces The Launch of New AI Capability in BasisEHR—The First AI-Powered EHR for Post-Acute Home Healthcare
15/04/2025 -
Tevogen Bio Commissions Databricks to Accelerate Development of PredicTcell, a Precision AI Tool for Target Prediction
15/04/2025 -
Best Steroids For Muscle Gain, Cutting, Steroid For Muscle Mass, Anabolic Steroids For Muscle Growth, Do Bodybuilders Take Steroids, Muscle Growth Steroids (By CrazyBulk)
15/04/2025 -
Best Steroids For Muscle Growth, Cutting, Muscle Building Steroids, Is Testosterone a Steroid, Buy Legal Steroids, Steroid to Build Muscle, Purchase Steroids (By CrazyBulk)
15/04/2025 -
EssilorLuxottica: Disclosure of transactions in own shares
15/04/2025 -
EssilorLuxottica: Déclaration de transactions sur actions propres
15/04/2025 -
Virbac: In the first quarter of 2025, revenue recorded solid growth of +4.9% at constant exchange rates and scope
15/04/2025 -
VIRBAC: Au premier trimestre 2025, le chiffre d'affaires a enregistré une solide croissance de +4,9% à taux de change et périmètre constants
15/04/2025 -
Best Muscle Growth Steroids, Cutting, Anabolic Steroids For Bodybuilding, Is Steroids Testosterone, Do Bodybuilders Use Steroids, Steroids For Muscles (By CrazyBulk)
15/04/2025 -
BioNexus Gene Lab Corp. Files 2024 Annual Report Highlighting Strategic Innovation, Operational Resilience, and Growth Trajectory
15/04/2025 -
AscellaHealth Announces Key Executive Promotions, Supporting Strategic Growth in the Life Sciences Business Unit
15/04/2025 -
Er-Kim Announces Exclusive Distribution Agreement with Polaris Pharmaceuticals to Commercialize Pegargiminase (ADZODI) for Malignant Pleural Mesothelioma (MPM) in Multiple EMEA Markets
15/04/2025 -
HealthEquity’s Expedited Claims Technology Wins Artificial Intelligence Excellence Awards
15/04/2025 -
Ezra Appoints Dr. Danna Chung as Chief Medical Officer
15/04/2025 -
Lyell Immunopharma Receives Regenerative Medicine Advanced Therapy (RMAT) Designation for LYL314 for the Treatment of Relapsed and/or Refractory Large B-Cell Lymphoma
15/04/2025
Pages